These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8247325)

  • 1. A dose-response study of dextrorphan in permanent focal ischemia.
    Graham SH; Chen J; Simon RP
    Neurosci Lett; 1993 Sep; 160(1):21-3. PubMed ID: 8247325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
    Graham SH; Chen J; Lan JQ; Simon RP
    J Pharmacol Exp Ther; 1996 Jan; 276(1):1-4. PubMed ID: 8558416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextrorphan reduces infarct volume, vascular injury, and brain edema after ischemic brain injury.
    Du C; Hu R; Hsu CY; Choi DW
    J Neurotrauma; 1996 Apr; 13(4):215-22. PubMed ID: 8860202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
    Slivka AP; Murphy EJ
    Exp Neurol; 2001 Jan; 167(1):166-72. PubMed ID: 11161604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive neuroprotective effects of dextrorphan and cycloheximide in rats subjected to transient focal cerebral ischemia.
    Du C; Hu R; Csernansky CA; Liu XZ; Hsu CY; Choi DW
    Brain Res; 1996 Apr; 718(1-2):233-6. PubMed ID: 8773794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia.
    Steinberg GK; Saleh J; Kunis D
    Neurosci Lett; 1988 Jun; 89(2):193-7. PubMed ID: 3292967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.
    Matucz E; Móricz K; Gigler G; Simó A; Barkóczy J; Lévay G; Hársing LG; Szénási G
    Brain Res; 2004 Sep; 1019(1-2):210-6. PubMed ID: 15306255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Yatsugi S; Takahashi M; Toya T; Ichiki C; Shimizu-Sasamata M; Yamaguchi T; Minematsu K
    Brain Res; 1998 May; 793(1-2):39-46. PubMed ID: 9630503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of nitric oxide synthesis does not reduce infarct volume in a rat model of focal cerebral ischaemia.
    Dawson DA; Kusumoto K; Graham DI; McCulloch J; Macrae IM
    Neurosci Lett; 1992 Aug; 142(2):151-4. PubMed ID: 1454209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
    Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
    Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
    Sydserff SG; Borelli AR; Green AR; Cross AJ
    Br J Pharmacol; 2002 Jan; 135(1):103-12. PubMed ID: 11786485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats.
    Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1996 Jun; 46(6):567-71. PubMed ID: 8767345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat: therapeutic time window for FK506 in transient focal ischemia.
    Arii T; Kamiya T; Arii K; Ueda M; Nito C; Katsura KI; Katayama Y
    Neurol Res; 2001 Oct; 23(7):755-60. PubMed ID: 11680517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM1 reduces infarct volume after focal cerebral ischemia.
    Lazzaro A; Seren MS; Koga T; Zanoni R; Schiavo N; Manev H
    Exp Neurol; 1994 Feb; 125(2):278-85. PubMed ID: 8313942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextromethorphan protects against cerebral infarction in a rat model of hypoxia-ischemia.
    Prince DA; Feeser HR
    Neurosci Lett; 1988 Mar; 85(3):291-6. PubMed ID: 3362419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat.
    Jiang N; Finklestein SP; Do T; Caday CG; Charette M; Chopp M
    J Neurol Sci; 1996 Aug; 139(2):173-9. PubMed ID: 8856649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
    Petty MA; Neumann-Haefelin C; Kalisch J; Sarhan S; Wettstein JG; Juretschke HP
    Eur J Pharmacol; 2003 Aug; 474(1):53-62. PubMed ID: 12909195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zileuton reduces inflammatory reaction and brain damage following permanent cerebral ischemia in rats.
    Tu XK; Yang WZ; Wang CH; Shi SS; Zhang YL; Chen CM; Yang YK; Jin CD; Wen S
    Inflammation; 2010 Oct; 33(5):344-52. PubMed ID: 20204486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimethylsulfoxide (DMSO) treatment reduces infarction volume after permanent focal cerebral ischemia in rats.
    Shimizu S; Simon RP; Graham SH
    Neurosci Lett; 1997 Dec; 239(2-3):125-7. PubMed ID: 9469672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cycloheximide reduces infarct volume when administered up to 6 h after mild focal ischemia in rats.
    Snider BJ; Du C; Wei L; Choi DW
    Brain Res; 2001 Nov; 917(2):147-57. PubMed ID: 11640900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.